No Data
No Data
TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating
Protara Therapeutics Announces Results From THRIVE-1, A Study Evaluating The Prevalence Of Choline Deficiency And Liver Injury In Patients Dependent On Parenteral Support
Express News | Protara Therapeutics Inc - Expects to Dose First Patient in Pivotal Pk Trial for IV Choline Chloride in Q1 2025
Express News | Protara Therapeutics Inc - Announces Results From Thrive-1
Express News | Protara Therapeutics Inc - Enrollment in Additional Cohorts Underway With Initial Results Expected in 1H'25
Express News | Protara Therapeutics Inc - Tara-002 Demonstrated Compelling Efficacy and Was Generally Well-Tolerated
No Data